New Horizons - myESR.org

www.myESR.org | EUROPEAN CONGRESS OF RADIOLOGY 2013CategoricalCoursesOncologic Imaging:Follow-up of Systemic and Local TherapiesFriday, March 8, 16:00–17:30, Room D2CC 719: Imaging after systemic therapies:the standardsModerator: E.L. van Persijn van Meerten; Leiden/NLA. RECIST criteriaY. Menu; Paris/FRB. PERCIST: evolving considerations for PET responsecriteria in solid tumoursT.F. Hany; Zurich/CHC. Evaluation of brain tumoursC. Majós; L’Hospitalet de Llobregat/ESSaturday, March 9, 08:30–10:00, Room D2CC 819: Imaging after systemic therapies:advanced techniquesModerator: D.-M. Koh; Sutton/UKA. What can we expect from biomarkersB. Van Beers; Clichy/FRB. MRI biomarkers: from acquisition to post-processingO. Lucidarme; Paris/FRC. Assessing the precision and accuracy of biomarkerimaging: is it reproducible?C.B. Sirlin; San Diego, CA/USSunday, March 10, 08:30–10:00, Room D2CC 1219: Assessing HCC responseModerator: R. Lencioni; Pisa/ITA. Systemic therapiesV. Vilgrain; Clichy/FRB. Endovascular therapiesR. Salem; Chicago, IL/USC. Ablative therapiesC. Ayuso; Barcelona/ESSunday, March 10, 14:00–15:30, Room D2CC 1419: Follow-up of thermal ablation (part I)Moderator: W. Prevoo; Amsterdam/NLA. The zone of cell death and collateral phenomena oncross-sectional imaging: from histopathology to thestandardisation of termsA. Denys; Lausanne/CHB. PET/CT for the evaluation of ablative therapy: Who?Where? When? Does it help?D. Deandreis; Villejuif/FRC. Everyday practice: MR and CT for evaluating response tothermal ablationC. Dromain; Villejuif/FRSunday, March 10, 16:00–17:30, Room D2CC 1519: Follow-up of thermal ablation (part II)Moderator: P.L. Pereira; Heilbronn/DEA. Follow-up imaging of thermal ablative therapies for lungtumoursA.R. Gillams; London/UKB. Follow-up imaging of percutaneous local treatment ofbone tumoursF. Deschamps; Villejuif/FRC. Follow-up imaging of thermal ablative therapies forkidney tumoursD.J. Breen; Southampton/UKMonday, March 11, 08:30–10:00, Room D2CC 1619: Follow-up of local treatmentsof breast cancerModerator: M.H. Fuchsjäger; Graz/ATA. MRI-guided HIFU therapies in the breastM. Sklair-Levy; Tel Aviv/ILB. Pre- and post- imaging appearance of breast lesionexcision system (BLES) lesionsS. Allen; Sutton/UKC. Common features and pitfalls in imaging the treated breastJ. Camps Herrero; Valencia/ESPreliminary Programme EdiciÓn Invierno | ECR 201361